Published in J Intern Med on May 01, 1999
Genetic risk variants for metabolic traits in Arab populations. Sci Rep (2017) 0.75
Actions of insulin-like growth factors. Annu Rev Physiol (1985) 3.80
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes (2000) 3.74
Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature (1982) 2.79
Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest (1981) 2.52
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Feasibility of balloon sinuplasty in patients with chronic rhinosinusitis: the Graz experience. Rhinology (2013) 2.21
The phenomenon of treatment failures in Human African Trypanosomiasis. Trop Med Int Health (2001) 2.18
Molecular evolution of the human adult alpha-globin-like gene region: insertion and deletion of Alu family repeats and non-Alu DNA sequences. Proc Natl Acad Sci U S A (1983) 2.07
Glucose-induced hypoglycaemia. Lancet (2002) 2.03
A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum (1996) 2.01
Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med (1987) 2.00
Out-of-hospital extracorporeal life support for cardiac arrest-A case report. Resuscitation (2011) 1.96
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92
Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem (1978) 1.88
Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) (1989) 1.83
Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology (1983) 1.72
Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clin Endocrinol (Oxf) (2001) 1.67
The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul (1981) 1.63
Spindle cell haemangioendothelioma: a clinicopathological and immunohistochemical study indicative of a non-neoplastic lesion. Histopathology (1991) 1.61
Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest (1992) 1.58
Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci U S A (1988) 1.55
Insulin-like growth factors in pygmies. The role of puberty in determining final stature. N Engl J Med (1987) 1.55
Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys (1975) 1.52
Co-expression of cytokeratin and vimentin filaments in rete testis and epididymis. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol (1991) 1.49
Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology (1980) 1.48
Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. Proc Natl Acad Sci U S A (1987) 1.47
Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage. Proc Natl Acad Sci U S A (1976) 1.45
Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia (1993) 1.45
Body size parallels insulin-like growth factor I levels but not growth hormone secretory capacity. Acta Endocrinol (Copenh) (1984) 1.43
Ex situ resection of primary cardiac tumors. Thorac Cardiovasc Surg (2003) 1.42
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia (2012) 1.42
Impact of the Eurotransplant high-urgency heart allocation system on the outcome of transplant candidates in Germany. Thorac Cardiovasc Surg (2011) 1.42
Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism (1978) 1.40
Creation of a self-made total artificial heart using combined components of available ventricular assist devices. Thorac Cardiovasc Surg (2008) 1.39
Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med (1983) 1.38
Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant. Int J Radiat Oncol Biol Phys (1993) 1.38
Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature (1986) 1.37
Repair of flail anterior leaflets of tricuspid and mitral valves by cusp remodeling. Ann Thorac Surg (1990) 1.37
Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices. A prospective study. Stroke (1996) 1.37
Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab (1984) 1.35
Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest (1986) 1.35
Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A (1989) 1.33
Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology (1979) 1.32
Diagnosis and treatment of nonocclusive mesenteric ischemia after open heart surgery. Ann Thorac Surg (2001) 1.32
Radical resection of cardiac sarcoma. Thorac Cardiovasc Surg (2004) 1.31
Impact of malignant hematological disorders on cardiac surgery. Cardiovasc Surg (2000) 1.30
Atomic structure of GTP cyclohydrolase I. Structure (1995) 1.30
Fibroblasts as an experimental tool in metabolic and hormone studies. II. Effects of insulin and nonsuppressible insulin-like activity (NSILA-S) on fibroblasts in culture. Eur J Clin Invest (1973) 1.29
Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Invest (1979) 1.28
Primary low-grade B-cell lymphoma of the conjunctiva: a mucosa-associated lymphoid tissue type lymphoma. Histopathology (1993) 1.26
Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Trop Med Int Health (2001) 1.25
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia (2011) 1.24
Direct effects of leptin on brown and white adipose tissue. J Clin Invest (1997) 1.22
Non-suppressible insulin-like activity of human serum. I. Physicochemical properties, extraction and partial purification. Biochim Biophys Acta (1966) 1.20
Insulin-like growth factors and insulin: comparative aspects. Diabetologia (1985) 1.20
Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Physiol (1996) 1.19
Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor. Eur J Biochem (1981) 1.18
Ultrasound findings in spontaneous extracranial vertebral artery dissection. Stroke (1993) 1.18
Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. Eur Respir J (2008) 1.17
Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh) (1985) 1.16
Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest (1992) 1.15
Antitrypanosomal and antiplasmodial activity of medicinal plants from Côte d'Ivoire. J Ethnopharmacol (2004) 1.15
Groups of adjacent contour segments for object detection. IEEE Trans Pattern Anal Mach Intell (2008) 1.14
Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J Clin Invest (1993) 1.13
Dwarfism in the pygmy. An isolated deficiency of insulin-like growth factor I. N Engl J Med (1981) 1.13
Crystal structure of a phosphatase-resistant mutant of sporulation response regulator Spo0F from Bacillus subtilis. Structure (1996) 1.13
Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs. Acta Endocrinol (Copenh) (1976) 1.12
Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I. J Clin Invest (1985) 1.12
The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. J Biol Chem (1975) 1.11
Intergenic DNA sequences flanking the pseudo alpha globin genes of human and chimpanzee. Nucleic Acids Res (1983) 1.11